A study analyzing use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen
Latest Information Update: 25 Jan 2023
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Therapeutic Use
Most Recent Events
- 25 Jan 2023 New trial record
- 01 Jan 2023 Results published in the Neurological Sciences